TrialHuman vaccines & immunotherapeutics2012

Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older.

Hideyuki Ikematsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.